Clinical and Translational Research Section — Department of Medicine
Dr. James Jett, Director of CTR Section and Dr. Jennifer Taylor-Cousar, Co-Director of CTR.
The Clinical and Translational Research Section (CTR) is an interdivisional program in the Department of Medicine that facilitates and promotes clinical and translational science discovery at National Jewish Health.
The CTR Section faculty consist of members from all of the divisions and sections of medicine, including: Allergy and Immunology, Cardiology, Community Research, Critical Care and Hospital Medicine, Environmental and Occupational Health, Gastroenterology, Mycobacterial and Respiratory Infections, Nephrology, Oncology, Pathology, Pulmonary Critical Care and Sleep Medicine, Psychosocial and Rheumatology. The clinical research activities vary tremendously and include interstitial and autoimmune lung disease, COPD, criticial care, sleep, cancer and GI.
On June 1, 2011 Dr. James Jett became the Director of the CTR Section and began a seminar series to ascertain specific needs of clinical and translational research faculty. Dr. Jett and Dr. Jennifer Taylor-Cousar (Co-Director of CTR) hold monthly lectures and open discussion in an effort to identify potential obstacles to conducting clinical research and securing grants for clinical trials by new and young clinical investigators. Presentations focus on the Clinical Research Unit (CRU), biostatistics, biobank and research database in an effort to familiarize clinical investigators with their available resources.
Faculty
The faculty in the Clinical and Translational Section have diverse research interests.
Research Interests
The Clinical and Translational Research Section has a faculty whose diverse research include:
- Asthma
- COPD
- ILD and Autoimmune Lung Disease
- Oncology
- Environmental and Occupational Medicine
- Sarcoidosis
- Rheumatology
- Sleep
- Cardiology
- Cystic Fibrosis
- Infectious Diseases – Including NTM
- GI
- Allergy/Immunology
- Critical Care
- Cancer
Research Resources
Clinical Trials and CRU
